Closing on Nov. 17: Investor Calendar + Company Spotlight

INVESTOR NETWORK is the go-to, one-stop site for shareholders, clients and prospective investors

The Perrigo Co.

The Perrigo Co.

Sector: Pharmaceutical Preparations Region: MI, United States

: | New York Stock Exchange: PRGO | Tel Aviv Stock Exchange: PRGO

Similar to: Imprimis Pharmaceuticals, Inc., Nicox SA, Cephalon, Inc.

The Perrigo Co. manufactures, distributes and markets pharmaceutical and nutritional products. It offers over the counter, generic prescription pharmaceuticals, nutritional products, infant formulas, active pharmaceutical ingredients and medical diagnostic products. The company operates through four reportable segments: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals and Active Pharmaceutical Ingredients. The Consumer Healthcare segment includes the sale of over the counter pharmaceutical, nutritional products and infant formulas. The Nutritionals segment develops, manufactures, markets and distributes store brand infant and toddler formula products, infant and toddler foods, vitamin, mineral and dietary supplement products and oral electrolyte solutions to retailers, distributors and consumers primarily in the U.S., Canada, Mexico and China. The Rx Pharmaceuticals segment develops, manufactures creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquid suspensions and solutions. The Active Pharmaceutical Ingredients segment identifies active pharmaceutical ingredients that will be critical to its pharmaceutical customers future product launches and development processes. The company was founded in 1887 and is headquartered in Allegan, MI.

News & Analysis

You may also be interested in: